CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L603. A total of 29 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,305 | -39.8% | 14,957 | 0.0% | 0.00% | – |
| Q2 2023 | $8,811 | +3.3% | 14,957 | 0.0% | 0.00% | – |
| Q1 2023 | $8,533 | -14.5% | 14,957 | 0.0% | 0.00% | – |
| Q4 2022 | $9,976 | -60.1% | 14,957 | -11.8% | 0.00% | – |
| Q3 2022 | $25,000 | +56.2% | 16,957 | +13.4% | 0.00% | – |
| Q2 2022 | $16,000 | -65.2% | 14,957 | 0.0% | 0.00% | – |
| Q1 2022 | $46,000 | -20.7% | 14,957 | 0.0% | 0.00% | – |
| Q4 2021 | $58,000 | -26.6% | 14,957 | 0.0% | 0.00% | – |
| Q3 2021 | $79,000 | -11.2% | 14,957 | 0.0% | 0.00% | – |
| Q2 2021 | $89,000 | – | 14,957 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 458,466 | $1,783,000 | 0.72% |
| Affinity Asset Advisors, LLC | 400,000 | $1,548,000 | 0.56% |
| Sio Capital Management, LLC | 422,598 | $1,644,000 | 0.50% |
| SPHERA FUNDS MANAGEMENT LTD. | 508,322 | $1,977,000 | 0.22% |
| Ikarian Capital, LLC | 99,422 | $385,000 | 0.06% |
| PURA VIDA INVESTMENTS, LLC | 102,324 | $398,000 | 0.01% |
| Schonfeld Strategic Advisors LLC | 322,373 | $1,254,000 | 0.01% |
| NEXT Financial Group, Inc | 23,852 | $93,000 | 0.01% |
| Point72 Asset Management, L.P. | 230,000 | $895,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 67,600 | $263,000 | 0.00% |